USANA Health Sciences (USNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -2.11 | -3.54 | -2.58 | -1.44 | -1.76 | -2.03 | |||
| Changes by years, y/y, % | -21% | +68% | -27% | -44% | +22% | +3.1% | |||
USANA Health Sciences. Debt/EBITDA
USANA Health Sciences. Debt/EBITDA, changes, %
USANA Health Sciences (USNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | -1.66 | -1.73 | -1.76 | -1.90 | -1.90 | -2.03 | ||
| Changes by years, y/y, % | -41% | -53% | +2% | +5% | +5% | |||
| Changes by quarters, q/q, % | -8% | +4% | +2% | +8% | 0% | |||